• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Estrogens and cell-cycle regulation in breast cancer.

作者信息

Foster J S, Henley D C, Ahamed S, Wimalasena J

机构信息

Dept of OB/GYN, Graduate School of Medicine, University of Tennessee, Knoxville, TN 37920, USA.

出版信息

Trends Endocrinol Metab. 2001 Sep;12(7):320-7. doi: 10.1016/s1043-2760(01)00436-2.

DOI:10.1016/s1043-2760(01)00436-2
PMID:11504672
Abstract

Clinical and experimental data have established that the leading cause of sporadic female breast cancer is exposure to estrogens, predominantly 17beta-estradiol. Recent advances in the understanding of cell-cycle control mechanisms have been applied to outline the molecular mechanisms through which estrogens regulate the cell cycle in cultured breast cancer cells, in particular, in MCF-7 cells. Here, we discuss how estrogens exert control over several key G1 phase cell-cycle regulators, namely cyclin D1, Myc, Cdk2, Cdk4, Cdk inhibitors and Cdc25A. Although the molecular mechanisms underlying estrogenic regulation of G1 phase regulators are far from clear, current evidence indicates that estrogens might regulate several key molecules required for S phase entry, this regulation being independent of cell-cycle transit per se.

摘要

相似文献

1
Estrogens and cell-cycle regulation in breast cancer.
Trends Endocrinol Metab. 2001 Sep;12(7):320-7. doi: 10.1016/s1043-2760(01)00436-2.
2
Growth factor, steroid, and steroid antagonist regulation of cyclin gene expression associated with changes in T-47D human breast cancer cell cycle progression.生长因子、类固醇及类固醇拮抗剂对细胞周期蛋白基因表达的调节与T-47D人乳腺癌细胞周期进程的变化相关。
Mol Cell Biol. 1993 Jun;13(6):3577-87. doi: 10.1128/mcb.13.6.3577-3587.1993.
3
Antiestrogen inhibition of cell cycle progression in breast cancer cells in associated with inhibition of cyclin-dependent kinase activity and decreased retinoblastoma protein phosphorylation.抗雌激素对乳腺癌细胞周期进程的抑制作用与细胞周期蛋白依赖性激酶活性的抑制及视网膜母细胞瘤蛋白磷酸化的降低有关。
Mol Endocrinol. 1995 Dec;9(12):1804-13. doi: 10.1210/mend.9.12.8614416.
4
Induction of G1 phase arrest in MCF human breast cancer cells by pentagalloylglucose through the down-regulation of CDK4 and CDK2 activities and up-regulation of the CDK inhibitors p27(Kip) and p21(Cip).五倍子酰葡萄糖通过下调细胞周期蛋白依赖性激酶4(CDK4)和细胞周期蛋白依赖性激酶2(CDK2)的活性以及上调细胞周期蛋白依赖性激酶抑制剂p27(Kip)和p21(Cip)来诱导MCF人乳腺癌细胞的G1期阻滞。
Biochem Pharmacol. 2003 Jun 1;65(11):1777-85. doi: 10.1016/s0006-2952(03)00156-4.
5
Mechanisms of growth arrest by c-myc antisense oligonucleotides in MCF-7 breast cancer cells: implications for the antiproliferative effects of antiestrogens.c-myc反义寡核苷酸诱导MCF-7乳腺癌细胞生长停滞的机制:对抗雌激素抗增殖作用的启示
Cancer Res. 2002 Jun 1;62(11):3126-31.
6
Effects of 60-Hz fields, estradiol and xenoestrogens on human breast cancer cells.60赫兹电场、雌二醇和外源性雌激素对人乳腺癌细胞的影响。
Radiat Res. 1996 Oct;146(4):444-52.
7
Inhibition of the melanoma cell cycle and regulation at the G1/S transition by 12-O-tetradecanoylphorbol-13-acetate (TPA) by modulation of CDK2 activity.通过调节CDK2活性,12 - O - 十四烷酰佛波醇 - 13 - 乙酸酯(TPA)对黑色素瘤细胞周期的抑制及在G1/S期转换的调控
Exp Cell Res. 1995 Nov;221(1):92-102. doi: 10.1006/excr.1995.1356.
8
Estrogen regulation of cell cycle progression in breast cancer cells.雌激素对乳腺癌细胞中细胞周期进程的调节。
J Steroid Biochem Mol Biol. 1998 Apr;65(1-6):169-74. doi: 10.1016/s0960-0760(98)00021-1.
9
Flavopiridol induces G1 arrest with inhibition of cyclin-dependent kinase (CDK) 2 and CDK4 in human breast carcinoma cells.黄酮哌啶醇通过抑制人乳腺癌细胞中的细胞周期蛋白依赖性激酶(CDK)2和CDK4诱导G1期阻滞。
Cancer Res. 1996 Jul 1;56(13):2973-8.
10
Regulation of cell cycle and cyclins by 16alpha-hydroxyestrone in MCF-7 breast cancer cells.16α-羟基雌酮对MCF-7乳腺癌细胞周期及细胞周期蛋白的调控
J Mol Endocrinol. 2001 Dec;27(3):293-307. doi: 10.1677/jme.0.0270293.

引用本文的文献

1
Exogenous Estrogens as Breast Cancer Risk Factors: A Perspective.外源性雌激素作为乳腺癌风险因素:一种观点。
Cancers (Basel). 2025 Aug 18;17(16):2680. doi: 10.3390/cancers17162680.
2
Estradiol Downregulates MicroRNA-193a to Mediate Its Anti-Mitogenic Actions on Human Coronary Artery Smooth Muscle Cell Growth.雌二醇下调微小RNA-193a以介导其对人冠状动脉平滑肌细胞生长的抗有丝分裂作用。
Cells. 2025 Jul 23;14(15):1132. doi: 10.3390/cells14151132.
3
Cell cycle plasticity underlies fractional resistance to palbociclib in ER+/HER2- breast tumor cells.
细胞周期可塑性是 ER+/HER2- 乳腺癌细胞对帕博西利部分耐药的基础。
Proc Natl Acad Sci U S A. 2024 Feb 13;121(7):e2309261121. doi: 10.1073/pnas.2309261121. Epub 2024 Feb 7.
4
HetFCM: functional co-module discovery by heterogeneous network co-clustering.HetFCM:基于异质网络共聚类的功能共模块发现。
Nucleic Acids Res. 2024 Feb 9;52(3):e16. doi: 10.1093/nar/gkad1174.
5
Stress keratin 17 and estrogen support viral persistence and modulate the immune environment during cervicovaginal murine papillomavirus infection.应激角蛋白 17 和雌激素支持病毒持续存在,并在宫颈阴道小鼠乳头瘤病毒感染期间调节免疫环境。
Proc Natl Acad Sci U S A. 2023 Mar 21;120(12):e2214225120. doi: 10.1073/pnas.2214225120. Epub 2023 Mar 14.
6
Transcriptomics indicate nuclear division and cell adhesion not recapitulated in MCF7 and MCF10A compared to luminal A breast tumours.转录组学表明,与腔 A 型乳腺癌相比,MCF7 和 MCF10A 中未再现核分裂和细胞黏附。
Sci Rep. 2022 Dec 3;12(1):20902. doi: 10.1038/s41598-022-24511-z.
7
Clinical Relevance of Estrogen Reactivity in the Breast Cancer Microenvironment.雌激素反应性在乳腺癌微环境中的临床相关性
Front Oncol. 2022 May 23;12:865024. doi: 10.3389/fonc.2022.865024. eCollection 2022.
8
2',3',4'-Trihydroxychalcone changes estrogen receptor α regulation of genes and breast cancer cell proliferation by a reprogramming mechanism.2',3',4'-三羟基查耳酮通过重编程机制改变雌激素受体α对基因的调控及乳腺癌细胞的增殖。
Mol Med. 2022 Apr 25;28(1):44. doi: 10.1186/s10020-022-00470-z.
9
Collateral-resistance to estrogen and HER-activated growth is associated with modified AKT, ERα, and cell-cycle signaling in a breast cancer model.在一个乳腺癌模型中,对雌激素和HER激活的生长的旁系抗性与AKT、ERα和细胞周期信号传导的改变有关。
Explor Target Antitumor Ther. 2022 Feb 28;3(1):97-116. doi: 10.37349/etat.2022.00074.
10
The functional role of Pescadillo ribosomal biogenesis factor 1 in cancer.佩斯凯迪洛核糖体生物合成因子1在癌症中的功能作用。
J Cancer. 2022 Jan 1;13(1):268-277. doi: 10.7150/jca.58982. eCollection 2022.